Tata India Pharma & HealthCare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 25 Sep 2026
- ₹33.19-0.52%1 day
- Return since launch
- 11.8%
- 52-week range
- ₹27.91 — ₹34.00
- AUM
- ₹1,565 Cr
Tata India Pharma & HealthCare Fund is a Sectoral-Pharma equity fund from Tata Mutual Fund with ₹1,565 Cr under management, launched in 2015. Over three years it has returned 11.8% a year, against 21.1% for its category. The expense ratio is 2.32% and the SEBI riskometer reading is Very High.
Performance
Tata India Pharma & HealthCare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +10.7% against +19.5% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 15.2% | −5.6 pts | 20.9% | 26.4% |
| 2Y | 9.3% | −7.6 pts | 16.8% | 15.2% |
| 3Y | 11.8% | −9.3 pts | 21.1% | 15.8% |
| 5Y | 16.3% | +2.0 pts | 14.3% | 18.0% |
| 7Y | 17.4% | −1.8 pts | 19.2% | 18.1% |
| 10Y | 16.9% | +3.3 pts | 13.7% | 16.9% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | -2.0% | −2.1 pts | 0.2% | -0.3% |
| 3M | 3.6% | −2.6 pts | 6.2% | 6.0% |
| 6M | 16.7% | −5.4 pts | 22.1% | 20.9% |
| 1Y | 10.7% | −10.2 pts | 20.9% | 19.5% |
| 2Y | 3.3% | −5.0 pts | 8.2% | 6.5% |
| 3Y | 18.9% | −2.2 pts | 21.1% | 20.1% |
| 5Y | 13.3% | −1.0 pts | 14.3% | 13.4% |
| 7Y | 20.5% | −1.9 pts | 22.4% | 21.3% |
| 10Y | 13.1% | −0.6 pts | 13.7% | 12.2% |
Since launch (4 Dec 2015): 11.8%
Calendar-year returns
Category average64.4%
19.1%
-8.0%
36.6%
40.0%
-4.9%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -4.9% | −2.9 pts | -2.0% |
| 2024 | 40.0% | −0.9 pts | 40.9% |
| 2023 | 36.6% | +0.3 pts | 36.2% |
| 2022 | -8.0% | +0.2 pts | -8.3% |
| 2021 | 19.1% | −2.6 pts | 21.7% |
| 2020 | 64.4% | −4.4 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.37%
Expense ratio as on 23 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.80%
- Brokerage
- 0.10%
- Transaction charges
- 0.01%
- Statutory levies
- 0.46%
- Exit load
- Exit load of 0.25% if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -3.01 | 0.74 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.99 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.83 | 1.05 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.25 | 1.63 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 16.35 | 15.68 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
Tata India Pharma & HealthCare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity99.5%
- Other0.5%
Market cap split
- Large23.6%
- Mid37.8%
- Small38.6%
- P/E
- 43.90
- P/B
- 5.93
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 8.43% | ₹132 Cr | +9.38% | +9.66% | +9.94% |
| Healthcare Global Enterprises Ltd. | Healthcare | 6.30% | ₹98.56 Cr | +5.87% | +5.04% | +4.85% |
| Divi's Laboratories Ltd. | Healthcare | 5.65% | ₹88.49 Cr | +5.80% | +5.94% | +3.90% |
| Abbott India Ltd. | Healthcare | 5.44% | ₹85.11 Cr | +5.41% | +5.60% | — |
| Rainbow Children's Medicare Ltd. | Healthcare | 4.47% | ₹70.04 Cr | +4.52% | +3.83% | +2.32% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 4.32% | ₹67.64 Cr | +4.56% | +5.00% | +5.15% |
| Cipla Ltd. | Healthcare | 4.27% | ₹66.78 Cr | +5.18% | +4.55% | +6.92% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 4.21% | ₹65.84 Cr | +4.02% | +3.04% | +2.04% |
| Max Healthcare Institute Ltd. | Healthcare | 3.80% | ₹59.55 Cr | +4.80% | +6.78% | +4.05% |
| Fortis Healthcare Ltd. | Healthcare | 3.30% | ₹51.63 Cr | +3.41% | +3.27% | +3.69% |
| Lupin Ltd. | Healthcare | 3.26% | ₹51.09 Cr | +2.76% | +3.08% | +4.79% |
| Syngene International Ltd. | Healthcare | 3.02% | ₹47.28 Cr | +2.65% | +2.39% | +1.42% |
| Bayer CropScience Ltd. | Chemicals | 3.01% | ₹47.18 Cr | +3.10% | +3.33% | — |
| Pfizer Ltd. | Healthcare | 2.92% | ₹45.76 Cr | +1.63% | — | — |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹45.58 Cr | +3.77% | +3.40% | +2.11% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 2.72% | ₹42.63 Cr | +3.26% | +1.82% | — |
| Procter & Gamble Health Ltd. | Healthcare | 2.51% | ₹39.22 Cr | +1.80% | — | — |
| Sai Life Sciences Ltd. | Healthcare | 2.41% | ₹37.67 Cr | +2.73% | +3.25% | +1.02% |
| Alkem Laboratories Ltd. | Healthcare | 2.35% | ₹36.80 Cr | +2.42% | +2.15% | +4.31% |
| Anthem Biosciences Ltd. | Healthcare | 2.14% | ₹33.44 Cr | — | — | — |
| FDC Ltd. | Healthcare | 2.10% | ₹32.90 Cr | +2.12% | +1.82% | +2.20% |
| Global Health Ltd. | Healthcare | 1.68% | ₹26.31 Cr | +2.20% | +1.50% | — |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.66% | ₹25.97 Cr | +1.68% | +2.71% | +3.09% |
| Sumitomo Chemical India Ltd. | Chemicals | 1.59% | ₹24.84 Cr | +0.49% | — | — |
| company:15106 | Healthcare | 1.59% | ₹24.93 Cr | — | — | +4.40% |
| Ajanta Pharma Ltd. | Healthcare | 1.57% | ₹24.51 Cr | +1.89% | +2.06% | +3.03% |
| company:17009 | Healthcare | 1.48% | ₹23.20 Cr | — | — | — |
| Manipal Health Enterprises Ltd. | Healthcare | 1.24% | ₹19.34 Cr | — | — | — |
| Metropolis Healthcare Ltd. | Healthcare | 1.11% | ₹17.32 Cr | +1.64% | +3.13% | +3.04% |
| Gillette India Ltd. | Consumer Staples | 1.09% | ₹17.03 Cr | +1.35% | — | — |
| Biocon Ltd. | Healthcare | 0.99% | ₹15.51 Cr | — | — | — |
| company:2717 | Chemicals | 0.95% | ₹14.95 Cr | +0.36% | — | +1.44% |
| Ipca Laboratories Ltd. | Healthcare | 0.90% | ₹14.13 Cr | 0.00% | 0.00% | +2.98% |
| company:20769 | Healthcare | 0.87% | ₹13.67 Cr | — | — | — |
| Dr. Agarwal's Health Care Ltd. | Healthcare | 0.71% | ₹11.05 Cr | +0.58% | +0.07% | +2.02% |
| company:20823 | Healthcare | 0.64% | ₹10.00 Cr | — | — | — |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 0.52% | ₹8.21 Cr | — | — | — |
| Others | Others | 0.51% | ₹7.64 Cr | +0.94% | +4.48% | +3.96% |
| company:14919 | Insurance | 0.50% | ₹7.88 Cr | +0.40% | — | — |
| Zim Laboratories Ltd. | Healthcare | 0.49% | ₹7.74 Cr | — | — | — |
| Jubilant Pharmova Ltd. | Healthcare | 0.25% | ₹3.97 Cr | +0.55% | +0.07% | — |
| Torrent Pharmaceuticals Ltd. | Healthcare | 0.12% | ₹1.89 Cr | +1.02% | +1.07% | +4.58% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Anthem Biosciences Ltd. | 0.01% | 2.14% | +2.13% |
| Glaxosmithkline Pharmaceuticals Ltd. | 4.66% | 2.72% | -1.94% |
| Concord Biotech Ltd. | 1.91% | 0.00% | -1.91% |
| company:15106 | 0.00% | 1.59% | +1.59% |
| company:17009 | 0.00% | 1.48% | +1.48% |
| Neuland Laboratories Ltd. | 1.25% | 0.00% | -1.25% |
| BASF India Ltd. | 0.97% | 0.00% | -0.97% |
| company:2717 | 0.00% | 0.95% | +0.95% |
| Ipca Laboratories Ltd. | 0.00% | 0.90% | +0.90% |
| company:20769 | 0.00% | 0.87% | +0.87% |
| Divi's Laboratories Ltd. | 6.36% | 5.65% | -0.71% |
| company:20823 | 0.00% | 0.64% | +0.64% |
| Lupin Ltd. | 2.64% | 3.26% | +0.62% |
| Jubilant Pharmova Ltd. | 0.83% | 0.25% | -0.58% |
| Dr. Lal Pathlabs Ltd. | 2.17% | 1.66% | -0.51% |
| company:14919 | 0.00% | 0.50% | +0.50% |
| Sai Life Sciences Ltd. | 2.89% | 2.41% | -0.48% |
| Biocon Ltd. | 0.52% | 0.99% | +0.47% |
| Healthcare Global Enterprises Ltd. | 5.85% | 6.30% | +0.45% |
| Global Health Ltd. | 2.13% | 1.68% | -0.45% |
| Rainbow Children's Medicare Ltd. | 4.90% | 4.47% | -0.43% |
| Apollo Hospitals Enterprise Ltd. | 3.90% | 4.32% | +0.42% |
| FDC Ltd. | 2.39% | 2.10% | -0.29% |
| Others | 0.61% | 0.32% | -0.29% |
| Max Healthcare Institute Ltd. | 4.07% | 3.80% | -0.27% |
| Manipal Health Enterprises Ltd. | 0.97% | 1.24% | +0.27% |
| Cipla Ltd. | 4.53% | 4.27% | -0.26% |
| Bayer CropScience Ltd. | 3.26% | 3.01% | -0.25% |
| Sanofi India Ltd. | 0.23% | 0.00% | -0.23% |
| Alkem Laboratories Ltd. | 2.58% | 2.35% | -0.23% |
| Abbott India Ltd. | 5.63% | 5.44% | -0.19% |
| Fortis Healthcare Ltd. | 3.12% | 3.30% | +0.18% |
| Sun Pharmaceutical Industries Ltd. | 8.59% | 8.43% | -0.16% |
| Pfizer Ltd. | 3.06% | 2.92% | -0.14% |
| Torrent Pharmaceuticals Ltd. | 0.00% | 0.12% | +0.12% |
| Mankind Pharma Ltd. | 3.02% | 2.91% | -0.11% |
| Procter & Gamble Health Ltd. | 2.42% | 2.51% | +0.09% |
| Syngene International Ltd. | 2.95% | 3.02% | +0.07% |
| Gillette India Ltd. | 1.15% | 1.09% | -0.06% |
| Ajanta Pharma Ltd. | 1.53% | 1.57% | +0.04% |
| Dr. Reddy's Laboratories Ltd. | 4.25% | 4.21% | -0.04% |
| Dr. Agarwal's Health Care Ltd. | 0.67% | 0.71% | +0.04% |
| Sanofi Consumer Healthcare India Ltd. | 0.55% | 0.52% | -0.03% |
| Zim Laboratories Ltd. | 0.46% | 0.49% | +0.03% |
| Metropolis Healthcare Ltd. | 1.12% | 1.11% | -0.01% |
| Sumitomo Chemical India Ltd. | 1.59% | 1.59% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.3% | 17.7% | 20.1% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.5% | 14.2% | 19.4% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.1% | 19.9% | 22.2% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.9% | 18.4% | 19.7% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.4% | 19.1% | 21.1% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.7% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund managers
- Rajat SrivastavaMr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT GhaziabadPrior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months16.72% absolute | ₹60,000 | ₹70,032 | 16.72% | |
| 1 year10.70% annualised | ₹1,20,000 | ₹1,27,188 | 5.99% | |
| 3 years18.94% annualised | ₹3,60,000 | ₹4,87,365 | 35.38% | |
| 5 years13.31% annualised | ₹6,00,000 | ₹8,55,378 | 42.56% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of Tata India Pharma & HealthCare Fund?
The NAV of Tata India Pharma & HealthCare Fund is ₹33.19 as on 25 Sep 2026.
What is the expense ratio of Tata India Pharma & HealthCare Fund?
The expense ratio of Tata India Pharma & HealthCare Fund is 2.32% per year.
What is the minimum SIP amount for Tata India Pharma & HealthCare Fund?
You can start a SIP in Tata India Pharma & HealthCare Fund with ₹3,000 a month.
What returns has Tata India Pharma & HealthCare Fund given?
Tata India Pharma & HealthCare Fund has returned 15.2% over 1 year, 11.8% over 3 years and 16.3% over 5 years (annualised).
Is there a lock-in or exit load on Tata India Pharma & HealthCare Fund?
Lock-in: None. Exit load: Exit load of 0.25% if redeemed within 30 days..
How risky is Tata India Pharma & HealthCare Fund?
Tata India Pharma & HealthCare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages Tata India Pharma & HealthCare Fund?
Tata India Pharma & HealthCare Fund is managed by Tata Mutual Fund, which runs 61 schemes with ₹2,31,388 Cr under management.